Ecolab Inc.(ECL) Stock Research - Grey Stern Research
Loading...

Ecolab Inc. (ECL) Stock Analysis

$252.68 (0.11%)

ECL Financial Performance


Use the table below to view Ecolab Inc.'s financial profile. This data is gathers from the latest available financial statements. Annual data is taken from the trailing 12 months of statements. All numbers are reported in US Dollars and so any foreign currencies are converted to USD so comparison's can be done.

Based on Financial Statements from Q4 - 2024

Metric Value Ranking among Peers
Price $252.68 -
52 Week Low $217.05 -
52 Week High $273.69 -
Market Cap $71.7 Billion 3/11
Gross Margin 43% 3/11
Profit Margin 12% 3/11
EBITDA margin 23% 3/11
Q4 - 2024 Revenue $4.0 Billion 4/11
Q4 - 2024 Earnings $472.9 Million 4/11
Q4 - 2024 Free Cash Flow $407.0 Million 4/11
Trailing 4 Quarters Revenue $15.7 Billion 5/11
Trailing 4 Quarters Earnings $2.1 Billion 4/11
Quarterly Earnings Growth 17% 7/11
Annual Earnings Growth 31% 4/11
Quarterly Revenue Growth 2% 3/11
Annual Revenue Growth 0% 3/11
Cash On Hand $1.3 Billion 6/11
Short Term Debt $615.7 Million 7/11
Long Term Debt $7.5 Billion 6/11

Ecolab Inc. Financial Metrics


Financial metrics are a set of useful numbers that can give key performance indicators of a company. The various metrics can include information about profitability, growth, and debt load. When combined and use properly they can tell an analyst a compelling fact-based story of how the company is currently performing. To compare Ecolab Inc.'s metrics versus it's peers make sure to run our peer analysis tool.

Valuation Metrics

Metric Value Ranking among Peers
PE 33.93 2/11
PS 4.55 3/11
PB 8.15 2/11
PC 57.02 2/11
Liabilities to Equity 1.55 4/11
ROA 0.09 4/11
ROE 0.24 2/11
Current Ratio 1.65 7/11
Quick Ratio 0.09 6/11
Long Term Debt to Equity 0.86 2/11
Debt to Equity 0.93 3/11
Burn Rate -69.87 10/11
Cash to Cap 0.02 6/11
CCR 0.86 5/11
EV to EBITDA 85.54 6/11
EV to Revenue 4.99 3/11

Company Details

Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through Global Industrial, Global Institutional & Specialty, and Global Healthcare & Life Sciences segments. The Global Industrial segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, metals and mining, power generation, pulp and paper, commercial laundry, petroleum, refining, and petrochemical industries. The Global Institutional & Specialty segment provides specialized cleaning and sanitizing products to the foodservice, hospitality, lodging, government and education, and retail industries. Its Global Healthcare & Life Sciences segment offers specialized cleaning and sanitizing products to the healthcare, personal care, and pharmaceutical industries, such as infection prevention and surgical solutions, and end-to-end cleaning and contamination control solutions under the Ecolab, Microtek, and Anios brand names. The company's Other segment offers pest elimination services to detect, eliminate, and prevent pests, such as rodents and insects in restaurants, food and beverage processors, educational and healthcare facilities, hotels, quick service restaurant and grocery operations, and other institutional and commercial customers. This segment also provides colloidal silica for binding and polishing applications in semiconductor, catalyst, and aerospace component manufacturing, as well as chemical industries; and products and services that manage wash process through custom designed programs, premium products, dispensing equipment, water and energy management, and reduction, as well as real time data management. It sells its products through field sales and corporate account personnel, distributors, and dealers. The company was founded in 1923 and is headquartered in Saint Paul, Minnesota.

CEO: Mr. Douglas Baker

Website: https://www.ecolab.com

Address: 1 Ecolab Place Saint Paul, MINNESOTA

Exchange: New York Stock Exchange

Industry: Specialty Chemicals

Ecolab Inc. Peer Analysis


A useful and more reliable way of seeing the health of a company is to compare it to other companies operating in the same sector. Below is our list of companies which we rank are the closest peers to Ecolab Inc.. If you feel that peers should be added or removed from this list please contact us. To run an in-depth peer analysis which compares many financial metrics click on the link below.

Stock Ticker Market Cap
LyondellBasell Industries N.V. LYB $22.9 Billion
Cabot Corporation CBT $4.6 Billion
Albemarle Corporation ALB $8.8 Billion
PPG Industries, Inc. PPG $24.6 Billion
The Sherwin-Williams Company SHW $86.9 Billion
RPM International Inc. RPM $15.0 Billion
International Flavors & Fragrances Inc. IFF $20.0 Billion
Westlake Corporation WLK $13.2 Billion
Air Products and Chemicals, Inc. APD $65.7 Billion
Linde plc LIN $219.8 Billion
Run Peer Analysis
Income Statement
Balance Sheet
Cash Flow Statement
ECL Income Statements
Quarter Year Revenue Earnings
Q4 2024 $ 4.0 Billion $472.9 Million
Q3 2024 $ 4.0 Billion $736.5 Million
Q2 2024 $ 4.0 Billion $490.9 Million
Q1 2024 $ 3.8 Billion $412.1 Million
Q4 2023 $ 3.9 Billion $405.2 Million
Q3 2023 $ 4.0 Billion $404.0 Million
Q2 2023 $ 3.9 Billion $329.7 Million
Q1 2023 $ 3.6 Billion $233.4 Million

View All

ECL Balance Sheets
Quarter Year Cash & Equivalents Total Assets Total Debt Total Equity
Q4 2024 $1.3 Billion $22.4 Billion $8.1 Billion $8.8 Billion
Q3 2024 $1.3 Billion $22.1 Billion $7.6 Billion $8.6 Billion
Q2 2024 $384.0 Million $21.5 Billion $8.1 Billion $8.3 Billion
Q1 2024 $479.9 Million $21.3 Billion $8.1 Billion $8.2 Billion
Q4 2023 $919.5 Million $21.8 Billion $8.6 Billion $8.1 Billion
Q3 2023 $1.0 Billion $21.9 Billion $9.0 Billion $7.8 Billion
Q2 2023 $554.2 Million $21.5 Billion $9.0 Billion $7.6 Billion
Q1 2023 $419.4 Million $21.3 Billion $9.0 Billion $7.3 Billion

View All

ECL Cash Flow Statements
Quarter Year freeCashFlow capitalExpenditure netChangeInCash
Q4 2024 $407.0 Million -$359.7 Million -$4.3 Million
Q3 2024 $550.3 Million -$236.4 Million $877.1 Million
Q2 2024 $414.2 Million -$196.9 Million -$95.9 Million
Q1 2024 $447.9 Million -$201.5 Million -$439.6 Million
Q4 2023 $852.5 Million $0 $852.5 Million
Q3 2023 $787.7 Million $0 $787.7 Million
Q2 2023 $573.4 Million $0 $573.4 Million
Q1 2023 $24.5 Million -$173.7 Million -$179.2 Million

View All